This inventor holds 2 USPTO granted patents. Top assignees: Aventis Pharmaceuticals Inc., Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Jean-Paul Casimir: Innovator in Chiral Chemistry
Introduction
Jean-Paul Casimir is a notable inventor based in Ermont, France. He has made significant contributions to the field of chiral chemistry, particularly in the preparation of chiral amines. With a total of 2 patents, his work has implications in pharmaceuticals and chemical synthesis.
Latest Patents
Jean-Paul Casimir's latest patents include innovative methods for the stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines. These inventions focus on methods for stereospecifically preparing [(1-optionally substituted aryl)- or (1-optionally substituted heteroaryl)]-2-substituted ethyl-2-amines, which possess chirality at the 2-position. His work also includes the development of intermediates for these substituted ethyl-2-amines.
Career Highlights
Throughout his career, Jean-Paul has worked with prominent companies in the pharmaceutical industry, including Rhône-Poulenc Rorer Pharmaceuticals Inc. and Aventis Pharmaceuticals Inc. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development.
Collaborations
Jean-Paul has collaborated with notable professionals in his field, including Luc Grondard and Patrick Leon. These partnerships have fostered a collaborative environment that enhances the development of new technologies and methodologies in chiral chemistry.
Conclusion
Jean-Paul Casimir's contributions to the field of chiral chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry and advance the science of stereochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile